Works matching IS 0167594X AND DT 2018 AND VI 139 AND IP 1


Results: 25
    1
    2
    3
    4
    5
    6
    7
    8
    9

    A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome

    Published in:
    Journal of Neuro-Oncology, 2018, v. 139, n. 1, p. 153, doi. 10.1007/s11060-018-2856-y
    By:
    • Adhikari, Narayan;
    • Biswas, Ahitagni;
    • Gogia, Ajay;
    • Sahoo, Ranjit Kumar;
    • Garg, Ajay;
    • Nehra, Ashima;
    • Sharma, Mehar Chand;
    • Bhasker, Suman;
    • Singh, Manmohan;
    • Sreenivas, Vishnubhatla;
    • Chawla, Rohan;
    • Joshi, Garima;
    • Kumar, Lalit;
    • Chander, Subhash
    Publication type:
    Article
    10
    11
    12

    Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 139, n. 1, p. 51, doi. 10.1007/s11060-018-2853-1
    By:
    • Baroni, Mirella;
    • Marie, Suely Kazue Nagahashi;
    • Fedatto, Paola Fernanda;
    • Andrade, Augusto Faria;
    • Suazo, Veridiana Kill;
    • Cruzeiro, Gustavo Alencastro Veiga;
    • de Paula Queiroz, Rosane;
    • Tone, Luiz Gonzaga;
    • Scrideli, Carlos Alberto
    Publication type:
    Article
    13
    14
    15

    Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 139, n. 1, p. 125, doi. 10.1007/s11060-018-2850-4
    By:
    • Kotrotsou, Aikaterini;
    • Elakkad, Ahmed;
    • Sun, Jia;
    • Thomas, Ginu A.;
    • Yang, Dongni;
    • Abrol, Srishti;
    • Wei, Wei;
    • Weinberg, Jeffrey S.;
    • Bakhtiari, Ali S.;
    • Kircher, Moritz F.;
    • Luedi, Markus M.;
    • de Groot, John F.;
    • Sawaya, Raymond;
    • Kumar, Ashok J.;
    • Zinn, Pascal O.;
    • Colen, Rivka R.
    Publication type:
    Article
    16
    17
    18
    19
    20

    Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 139, n. 1, p. 33, doi. 10.1007/s11060-018-2845-1
    By:
    • Bezerra Salomão, Karina;
    • Cruzeiro, Gustavo Alencastro Veiga;
    • Bonfim-Silva, Ricardo;
    • Geron, Lenisa;
    • Ramalho, Fernando;
    • Pinto Saggioro, Fabiano;
    • Serafini, Luciano Neder;
    • Antunes Moreno, Daniel;
    • de Paula Queiroz, Rosane Gomes;
    • dos Santos Aguiar, Simone;
    • Cardinalli, Izilda;
    • Yunes, José Andres;
    • Brandalise, Silvia Regina;
    • Brassesco, Maria Sol;
    • Scrideli, Carlos Alberto;
    • Gonzaga Tone, Luiz
    Publication type:
    Article
    21
    22
    23
    24
    25